In addition, there is evidence in the literature that mutant RAS cell lines (so-called as they were initially identified in "rat sarcoma" cells) are more radio-resistant compared to wild type RAS [14, 15]; a difference that has recently been shown to affect overall survival following radioembolisation [16, 17], suggesting a more detailed approach to accurate dose response profiling is needed.
In mouse 3T3 fibroblasts a switch to amoeboid movement was observed upon p53 inactivation [14], while up-regulation of the Rho/ROCK signalling was found in highly metastatic rat sarcoma cells, together with the loss of MMP2 activity and an increased generation of protrusive forces, typical of the amoeboid movement [21].
Indeed, high rates of serine biosynthesis have been reported in human colon carcinoma, rat sarcoma, and rat hepatoma cell lines, attesting to a possible role in tumor cell growth.
Growth of syngeneic transplants of a 3-methylcholanthrene induced rat sarcoma was suppressed when tumour cells were injected in admixture with BCG.
Though, increase in Sin3B expression was also observed upon Rat Sarcoma (Ras) oncogene activation and adriamycin treatment to cells [ 14, 40]; the mechanism of Sin3 up-regulation is still far from clear.
MiR-143 targets Kirsten rat sarcoma viral oncogene homolog (KRAS), ELK1, myosin 6, B cell lymphoma 2 (BCL-2), and extracellular signal-regulated kinase 5 (ERK).
PGE2 induces growth of tumor epithelial cells by binding the PGE2 receptor and activating rat sarcoma protein (RAS) and phosphatidyl inositol 3 kinase (PI3K), which activate signaling pathways that ultimately lead to proliferation and cell division [ 205– 205].
Both the pharmacologic and genetic inhibition of CYPD fail to prevent ferroptosis as triggered by erastin, a small molecule that is selectively lethal for cancer cells expressing oncogenic variants of Harvey rat sarcoma viral oncogene homolog (HRAS).
BRAF is a key member of the rat sarcoma (RAS) mitogen-activated protein kinase (MAPK) pathway which regulates cell growth and proliferation.
